肝硬化患者腹水感染与血清降钙素原的相关性分析
[Abstract]:Objective To investigate the correlation between ascites infection and serum procalcitonin (PCT) in patients with cirrhosis and to provide reference for the diagnosis of ascites infection in cirrhosis.Methods 50 patients with viral hepatitis and ascites bacterial peritonitis who were treated in hospital from April 2013 to April 2015 were selected as experimental group and 50 patients with viral hepatitis and ascites were not infected. Patients with infection were taken as control group. Ascites samples of test group were collected for bacterial culture, identification and drug susceptibility test. Serum PCT, polymorphonuclear leukocyte (PMN) and white blood cell (WBC) were detected in both groups. The positive rate of bacterial culture in ascites, the distribution of serum PCT test results, and the changes of PTC concentration in each period were observed. A total of 133 pathogenic bacteria were isolated from the water samples, 52 of them were Gram-positive bacteria (39.10%), 65 of them were Gram-negative bacteria (48.87%), 15 of them were fungi (11.28%) and 1 of them was acid-fast bacilli (0.75%). The results of PTC, PMN and WBC in the serum of the experimental group were significantly higher than those of the control group (P 0.05), and the PCT in the serum was 0.5 ng/ml as the positive limit, while the blood was 0.5 ng/ml as the positive limit. The sensitivity of serum PCT to the diagnosis of peritonitis was 96.00%. The control group was all negative. With the intervention of treatment, ascites infection was improved in the experimental group, and the serum PCT level was also decreased, while the serum PCT level in the control group was not significantly changed. Sensitivity has a high clinical reference value for the diagnosis and treatment of cirrhosis patients with ascites infection. In the treatment of cirrhosis patients with ascites infection, it is necessary to select reasonable antibiotics, and timely bacterial culture and drug sensitivity test.
【作者单位】: 重庆医科大学附属永川医院消化内科;重庆医科大学附属永川医院感染科;
【基金】:重庆市卫生局基金资助项目(2012-2-177)
【分类号】:R575.2
【相似文献】
相关期刊论文 前10条
1 郭云霞;;肝硬化自发性细菌性腹膜炎腹水感染的细菌分布及耐药性分析[J];中国实用医药;2013年21期
2 郭长青,黄宏春,李继昌,宁寒冰;肝硬化自发性腹水感染患者肠通透性检测的临床意义[J];中华内科杂志;2004年07期
3 胡琳琳;黄宏春;;肝硬化自发性腹水感染患者肠通透性检测的临床意义[J];中原医刊;2006年14期
4 丁熠;陈金联;朱金水;;肝硬化患者腹水感染致病菌菌谱变化与药敏分析[J];世界华人消化杂志;2006年10期
5 党燕;于艳华;刘新;张立丽;陈铭;娄金丽;;血清降钙素原和内毒素在肝硬化患者腹水感染中的诊断价值[J];首都医科大学学报;2014年04期
6 周子成;江正辉;;自发性细菌性腹膜炎[J];辽宁医学杂志;1988年03期
7 卜昕;张文瑾;范振平;何卫平;蔡少平;吉英杰;;肝硬化并发自发性细菌性腹膜炎患者腹水感染161例的细菌种类及耐药分析[J];中华临床医师杂志(电子版);2012年13期
8 张春平;肝硬化患者肠细菌过度生长为自发性腹水感染的一个因素?[J];国外医学(内科学分册);2003年12期
9 李胜军;;舒普深腹腔注药治疗严重肝病腹水感染的效果观察[J];现代诊断与治疗;2014年06期
10 章文华;陈鉴;程海燕;沈哲;;肝硬化并发自发性腹膜炎患者腹水感染的细菌分布及耐药性分析[J];中华医院感染学杂志;2013年24期
相关会议论文 前1条
1 许青田;;腹水超滤浓缩回输治疗肝硬化顽固性腹水[A];第7届全国疑难及重症肝病大会论文集[C];2013年
,本文编号:2213140
本文链接:https://www.wllwen.com/yixuelunwen/xiaohjib/2213140.html